Gina Maltas

555 total citations
8 papers, 375 citations indexed

About

Gina Maltas is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Gina Maltas has authored 8 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Gina Maltas's work include Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (4 papers) and Infectious Diseases and Tuberculosis (3 papers). Gina Maltas is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (4 papers) and Infectious Diseases and Tuberculosis (3 papers). Gina Maltas collaborates with scholars based in United States, Uganda and Canada. Gina Maltas's co-authors include Susan E. Dorman, John Bernardo, Grace Muzanye, Margarita E. Villarino, Dick Menzies, Eric Nuermberger, Shurjeel Choudhri, Nesri Padayatchi, Lorna Bozeman and Wendy Cronin and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Clinical Infectious Diseases and CHEST Journal.

In The Last Decade

Gina Maltas

8 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gina Maltas United States 8 329 270 134 28 24 8 375
Melissa Bauer Canada 6 477 1.4× 376 1.4× 193 1.4× 47 1.7× 18 0.8× 8 550
А. К. Стрелис Russia 12 484 1.5× 407 1.5× 204 1.5× 25 0.9× 33 1.4× 23 590
Julian te Riele South Africa 6 297 0.9× 231 0.9× 90 0.7× 30 1.1× 8 0.3× 7 338
Elize Pietersen South Africa 9 359 1.1× 288 1.1× 126 0.9× 38 1.4× 9 0.4× 13 430
Valiantsin Rusovich Denmark 6 274 0.8× 227 0.8× 93 0.7× 22 0.8× 33 1.4× 13 337
Anja Reuter South Africa 13 400 1.2× 276 1.0× 114 0.9× 61 2.2× 14 0.6× 31 469
Veriko Mirtskhulava Georgia 11 448 1.4× 323 1.2× 167 1.2× 36 1.3× 14 0.6× 17 551
Dylan B. Tierney United States 8 386 1.2× 262 1.0× 131 1.0× 42 1.5× 10 0.4× 16 452
Julia Ershova United States 13 409 1.2× 334 1.2× 139 1.0× 42 1.5× 17 0.7× 28 486
Frederick Haraka Tanzania 8 442 1.3× 327 1.2× 196 1.5× 56 2.0× 15 0.6× 18 510

Countries citing papers authored by Gina Maltas

Since Specialization
Citations

This map shows the geographic impact of Gina Maltas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gina Maltas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gina Maltas more than expected).

Fields of papers citing papers by Gina Maltas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gina Maltas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gina Maltas. The network helps show where Gina Maltas may publish in the future.

Co-authorship network of co-authors of Gina Maltas

This figure shows the co-authorship network connecting the top 25 collaborators of Gina Maltas. A scholar is included among the top collaborators of Gina Maltas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gina Maltas. Gina Maltas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lippincott, Christopher K., et al.. (2022). Tuberculosis treatment adherence in the era of COVID-19. BMC Infectious Diseases. 22(1). 800–800. 16 indexed citations
2.
Lippincott, Christopher K., et al.. (2022). Programmatic Adoption and Implementation of Video-Observed Therapy in Minnesota: Prospective Observational Cohort Study. JMIR Formative Research. 6(8). e38247–e38247. 8 indexed citations
3.
Chitnis, Amit S., Christopher J. Hoffmann, Larry W. Chang, et al.. (2021). Real-world implementation of video-observed therapy in an urban TB program in the United States. The International Journal of Tuberculosis and Lung Disease. 25(8). 655–661. 17 indexed citations
4.
Marks, Suzanne M., Wendy Cronin, Gina Maltas, et al.. (2013). The Health-System Benefits and Cost-effectiveness of Using Mycobacterium Tuberculosis Direct Nucleic Acid Amplification Testing to Diagnose Tuberculosis Disease in the United States. Clinical Infectious Diseases. 57(4). 532–542. 32 indexed citations
5.
Dorman, Susan E., John L. Johnson, Stefan Goldberg, et al.. (2009). Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 180(3). 273–280. 184 indexed citations
6.
Guerra, Renata Leborato, Nancy Hooper, James F. Baker, et al.. (2007). Use of the Amplified Mycobacterium tuberculosis Direct Test in a Public Health Laboratory. CHEST Journal. 132(3). 946–951. 35 indexed citations
7.
Nettles, Richard E., Karla Alwood, Gina Maltas, et al.. (2004). Risk Factors for Relapse and Acquired Rifamycin Resistance after Directly Observed Tuberculosis Treatment: A Comparison by HIV Serostatus and Rifamycin Use. Clinical Infectious Diseases. 38(5). 731–736. 61 indexed citations
8.
Bur, Sarah, J. E. Golub, John A. Armstrong, et al.. (2003). Evaluation of an extensive tuberculosis contact investigation in an urban community and jail.. PubMed. 7(12 Suppl 3). S417–23. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa Bauer Breakdown of academic impact, for papers by А. К. Стрелис Breakdown of academic impact, for papers by Julian te Riele Breakdown of academic impact, for papers by Elize Pietersen Breakdown of academic impact, for papers by Valiantsin Rusovich Breakdown of academic impact, for papers by Anja Reuter Breakdown of academic impact, for papers by Veriko Mirtskhulava Breakdown of academic impact, for papers by Dylan B. Tierney Breakdown of academic impact, for papers by Julia Ershova Breakdown of academic impact, for papers by Frederick Haraka
Rankless by CCL
2026